.
His words of 55 years ago bear repeating in -that they outline the philosophy upon which clinical investigation has moved forward. like to quote briefly from the introduction to the first Herter Lecture as follows:
'Laboratory methods as applied to the study of clinical medicine have come to stay; instruments and methods of precision are gradually relieving medicine of its past stigma; they are lifting it to the plane of its sister sciences, its true and proper status. We have been too content in the past with opinion. In the future we shall rest our case upon fact.' (Lewis, I9I5.) I would like to turn to the subject of my lecture by examining the history of clinical investigation of ischaemic heart disease. The modem era begins with Sir Thomas who in his Billings Lecture in Chicago in I93I summarized the descriptive observations which had gone before and pointed the way for future studies (Lewis, I932) . The first major investigative study on current decade and list coronary arteriography as one of the important developments, but may well consider it to be important because it brought many patients with ischaemic heart disease into the haemodynamic laboratory for study. Before I960, few patients with coronary heart disease were subjected to haemodynamic evaluation, as such a study would have been purely investigational and without any potential for therapeutic benefit.
The active investigation of the past five years has contributed to the current concept of the pathophysiology of myocardial ischaemia depicted in Fig. 2 We have carefully examined the possibility that these haemodynamic alterations might be attributed at least in part to the administration of contrast material and feel certain that this is not the case. As further evidence for this, we have examined the haemodynamic changes that follow injections of contrast material which are not associated with anginal attacks. In only 2 of 23 such patients did the left ventricular end-diastolic pressure exceed 20 mm. Hg. The two possible explanations for the observation of increased left ventricular enddiastolic pressure in association with angina pectoris are presented diagrammatically in To illustrate the two explanations for the increased end-diastolic pressure in ischaemic heart disease, the bottom of this loop or the Fig. 6 , 7, and 8. In Fig. 6 , the resting heart rate is 72 and the left ventricular pressure is easily measured at the termination of the 'a' wave. A pacing catheter in the right atrium or -*coronary sinus is used to increase the heart rate by IO beats a minute increments until anginal pain or ST segment changes appear.
In Fig. 7 the paced heart rate is IO beats a minute and it is not possible to clearly identify N the point at which the end-diastolic pressure should be measured. It can be seen, however, that the early and lowest diastolic pressure has risen and that this rise preceded the onset of pain. In Fig. 8 , the pacemaker has been turned off and the left ventricular enddiastolic pressure, which is difficult to measure during pacing, is clearly raised in the beats which immediately follow the end of the pacing. The pressure can be seen to rise during the first two beats at the slower spontaneous rate.
In Fig. 9 , the experience with 3I patients subjected to pacing stress testing has been summarized (Friesinger, Conti, and Pitt, I967) . In the bottom panels it can be noted that in the absence of angina there was no (Pitt and Gregg, I968) .
It was shown that as heart rate was increased by pacing, the cardiac output rose initially, but soon reached a plateau, and failed to increase more with further increases in rate. In contrast, it is seen that coronary blood flow continues to rise as the heart rate is increased by the pacemaker. This progressive rise in coronary flow which is linked to heart rate reflects the increase in myocardial oxygen consumption which is associated with tachycardia. These observations suggested that a similar technique might be applied in clinical investigation to show the inability of patients with ischaemic heart disease to increase myocardial blood flow in proportion to the increased myocardial oxygen consumption required by the tachycardia.
We used the xenon method to study the response of myocardial blood flow to pacinginduced tachycardia in patients (Ross et al., I964; Conti et al., 1970) . A saline solution of radioactive xenon is injected through the arteriographic catheter into the coronary artery, and after injection the disappearance of radioactivity from the heart is monitored by a scintillation counter positioned over the praecordium. The rate of disappearance of radioactivity is proportional to the blood flow to the region into which the gas has diffused. The larger the flow, the steeper the disappearance curve.
The results of a single experiment are shown in Fig. I2 to illustrate the experimental procedure. Myocardial blood flow has been measured by xenon disappearance before, during, and after pacing-induced tachycardia. This response was the opposite of that which was anticipated and a number of explanations for this set of observations can be offered.
One possible explanation is that the area of ischaemic myocardium is relatively small compared to the entire mass of myocardium in which flow is measured by the xenon wash-Pathophysiology of coronary circulation i8I out. The flow in the normal, nonischaemic area is increased because it has to do more 'work to compensate for the dysfunction of the ischaemic area and hence its oxygen consumption and flow are increased (Rees and Redding, I969). An alternative or perhaps an additional explanation would be the liberation of a substance from the ischaemic tissue which produced dilatation in the surrounding areas. The same substance might produce pain and hyperaemia. This might well be the 'P' substance with which Thomas Lewis was concerned (I932). More recent work with vasoactive substances in ischaemia has led to the suggestion by Berne that adenosine may be liberated from ischaemic tissue and serve as a powerful vasodilator (Rubio and Berne, I969) . Another powerful vasoactive substance is bradykinin which has been shown to be a coronary vasodilator and, under other circum--,,stances, to produce pain (Maxwell, Elliott, and Kneebone, I962; Armstrong et al., 1954) . These two facts suggested that bradykinin might play a role in the haemodynamic response to myocardial ischaemia and, indeed, wight be the substance responsible for the ischaemic pain, the search for which was initiated by Thomas Lewis.
Vasoactive substances -the kallikrein system These considerations of the possible role of the kallikrein system and bradykinin in angina pectoris led to a series of experiments in which the kallikrein system was studied in patients during pacing-induced myocardial ischaemia. This was a collaborative effort with the blood samples being collected during pacing studies, identical to those previously described, performed at The Johns Hopkins Hospital by Drs. Pitt and Conti and the kallikrein assays being performed by Drs.
Colman and Mason at the Massachusetts General Hospital (Pitt et al., I969) . The operation of the kallikrein system of plasma is outlined in Fig. 14 . Bradykinin is the pain-producing substance which is also a vasodilator and it is the end-product of a reaction which is initiated by Factor XII or the Hageman Factor. As a result of activation, the concentration of kallikreinogen in the serum falls. It is kallekreinogen which is measured and, therefore, a decrease in the concentration of this substance is indicative of activation of the system.
The results of kallikreinogen assays on samples of blood collected from the coronary sinus and aorta of 17 patients before, during, and after right atrial pacing are shown in Fig.  I5 . The (Lewis, 1932) .
Thomas Lewis The microsphere studies have also added useful information concerning the mechanism of action of nitroglycerin. The experiment depicted in Fig. I9 is similar to that in Fig. i8 but an injection of microspheres has been made after an occlusion which was preceded by the administration of nitroglycerin. Nitroglycerin did not result in an increase in the circ/desc ratio and hence, there was no increase in total flow into the area of ischaemia distal to the occlusion. There was, however, an increase in the endo/epi ratio in the ischaemic area which indicates that the blood flow to the endocardium had been improved.
Much has been learned about the pathophysiology of ischaemic heart disease since the time of Sir Thomas Lewis, and the rate at which new information is being acquired is increasing. Emphasis has shifted from haemodynamics to considerations of vasoactive substances and myocardial blood flow distribution. Many questions first posed by Sir Thomas Lewis still remained unanswered and foremost among these is the question concerning the cause of ischaemic pain.
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